Glenmark's post-marketing surveillance shows no safety concerns on use of Favipiravir for COVID-19

Sep 15, 2021

New Delhi [India], September 15 : The Glenmark Pharmaceuticals' post-marketing surveillance (PMS) study has shown no safety concerns with the use of Favipiravir (FabiFlu®[?])...

Glenmark concludes post marketing surveillance (PMS) study on Favipiravir (FabiFlu®)

Sep 15, 2021

Mumbai (Maharashtra) [India], September 15 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced the successful completion of its Post Marketing Surveillance...

Glenmark releases interim data from PMS Study on Favipiravir (FabiFlu®)

Jun 09, 2021

Mumbai (Maharashtra) [India], June 9 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced interim data of 503 patients from its Post...

Glenmark commences 1000 patients Post Marketing Surveillance study with COVID-19 who are administered FabiFlu®

Jul 13, 2020

Mumbai (Maharashtra) [India], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a Post Marketing Surveillance...

Understanding Portfolio Management Services

Aug 18, 2023

New Delhi [India], August 18: Portfolio Management Services (PMS) offer customized investment solutions through – professional portfolio managers to create wealth for you.

Nordic PMs condemn Russian aggression against Ukraine

May 04, 2022

Copenhagen [Denmark], May 4 : The Nordic Prime Ministers strongly condemned the "unlawful and unprovoked aggression" against Ukraine by Russian Forces, the joint statement...